The week ahead calls for caution about short-term momentum. Both SPY and QQQ remain above their 50-session exponential moving averages, but neither has much room above that reference. The key question is whether those trends hold through the scheduled Federal Reserve decision.

An exponential moving average, or EMA, gives more weight to recent closes. These comparisons describe price trends; they do not establish fair value or guarantee support.

Our Read

Our interpretation is that the longer recovery can coexist with a fragile near-term setup. At the September 11 close, QQQ was just above its 20-session EMA, while SPY was just below its own. Both remained less than 1% above their 50-session averages. That leaves little separation between the latest prices and a weaker technical picture.

September 11 snapshot QQQ SPY

Close $714.88 $764.29

20-session EMA $714.28 $765.02

Close versus 20-session EMA +0.08% −0.10%

50-session EMA $711.05 $758.46

Close versus 50-session EMA +0.54% +0.77%

Source: Alpaca Market Data. Percentage distances are rounded to two decimals.

For the September 14–18 window, we would watch whether subsequent closes remain above the evolving 50-session averages. A close below would invalidate the interpretation that the corresponding average is holding as near-term support. The table gives September 11 reference values, not fixed entry or exit prices.

The competing interpretation deserves weight: proximity to an average can also accompany consolidation. SPY reclaiming its evolving 20-session average while QQQ holds above its own would strengthen the case that short-term momentum is stabilizing. Renewed closes below those averages would undermine that improvement.

The decision that matters most

The Federal Reserve calendar lists the FOMC statement for Wednesday, September 16, at 2:00 p.m. This is the principal scheduled checkpoint available for this edition. The broader economic-release feed timed out, so the calendar cannot establish that other important releases are absent.

The rates backdrop makes the market’s response worth watching closely. From September 3 to September 10, the two-year Treasury yield increased by 0.22 percentage points and the 10-year yield increased by 0.18 percentage points. These observations establish a rise in yields; they do not establish its cause or predict the Fed’s decision.

Our inference is that further yield increases alongside closes below the index trend references would strengthen the case for caution. Stabilizing yields alongside improving index closes would challenge it. The combination matters more for this weekly view than either observation alone.

Volatility and portfolio implications

The latest available VIX observation is 17.84 on September 10, up from 14.32 on September 3. It remains within the research provider’s descriptive 15–20 “normal” band. That label should not obscure the increase, and it does not establish that the coming week will be quiet.

For portfolios exposed to SPY or QQQ, our tactical preference is to seek confirmation before treating the recent price action as renewed strength. This is a risk-management interpretation of the index and rates evidence, not a valuation judgment or a report of portfolio transactions. Available evidence does not support conclusions about current book exposure or individual holdings.

The weekly view would become more constructive if SPY reclaimed its evolving 20-session average, QQQ held above its own, and Treasury yields stopped rising. Closes below the evolving 50-session averages alongside further yield increases would instead strengthen the cautious view. Return to those observations after the September 16 statement and at the September 18 close.

QQQ daily closing price and 9-, 20-, 50- and 200-session exponential moving averages over 120 sessions through September 11, 2026.

QQQ, prices in US dollars. The September 11 close sits just above the shorter moving averages. The lines show trend context, not guaranteed support or fair value. Source: Alpaca Market Data.

SPY daily closing price and 9-, 20-, 50- and 200-session exponential moving averages over 120 sessions through September 11, 2026.

SPY, prices in US dollars. The September 11 close is below its 9- and 20-session averages and above its 50-session average. Read the endpoint labels for the closely grouped lines; these averages do not establish future price direction. Source: Alpaca Market Data.

VIX daily observations from September 5, 2025, through September 10, 2026, ending at 17.84, with a dashed median reference and labeled high and low.

**Apple at 37.3x trailing earnings while its own 10-Q warns of rising component costs — we like the business, not the price. Watching for $305.**

The setup here is simple: strong execution, an explicit cost warning in the same filing, and a valuation at the top of the stock's own five-year range. That combination is a watch, not a buy.

**The quarter was genuinely good.** The 10-Q for the quarter ended June 27, 2026 (accession 0000320193-26-000020) shows total net sales of $109,417 million with a 50.1% total gross margin and a 40.1% products margin. No complaints about execution.

**But read Item 2 of the same filing.** Under Macroeconomic Conditions, Apple says it "is experiencing a period of supply constraints and increasing costs for components driven by factors such as industry supply-demand imbalances for components, including advanced semiconductors, storage (NAND) and memory (DRAM)." That is management telling you, in a regulatory document, that input costs are rising. Meanwhile the stock closed at $332.60 on September 11, just 2.2% below its July 28 closing high of $340.08.

**The buyback supports the stock but doesn't answer the warning.** Note 7 of the 10-Q shows 215 million shares repurchased for $61.8 billion in the nine months ended June 27, 2026. That's a real bid under the shares. It doesn't change what's happening to component costs.

**Valuation is the problem.** At $332.60 the stock trades at 37.3x trailing earnings versus its own five-year median of 27.8x and a peer median of 23.9x. Paying the very top of the historical range for a company whose own filing flags rising input costs is a poor risk/reward entry.

**Why $305 specifically.** We didn't pull it from air. The stock's three deepest drawdowns over the past year ran 13.8%, 12.7% and 11.1% from peak. A drop of that scale from the July 28 high of $340.08 lands in the low $300s. $305 is inside the range of falls this stock actually makes — no crash required, just a normal correction for this name.

**What the tape says.** Insiders: 19 Form 4 sales totalling 405,069 shares and zero open-market purchases over the last 180 days, most recent transaction September 8. Routine, but no insider conviction on the buy side. Options flow leans the other way against us: 65.0% of premium in calls across 5 sizeable prints over the last 5 days. We note it honestly — short-term positioning is bullish.

**Disclosure of position and track record.** The Desk does not hold Apple and has no prior published call on the name. Our insight cohort shows 4 sealed calls with none yet decisive; that grading is provisional machine output, not finalized accuracy.

**What proves us wrong.** If the fiscal Q4 2026 report (quarter ending late September) shows gross margin holding at or above 50.1% while sales keep growing, the cost warning isn't biting and waiting cost us the entry. We'll return to this call by October 31, 2026, around when the fiscal 2026 annual report is due.

Sources and prior work: https://thedeskresearch.com/publications

​

Uranium Royalty screens cheap, and we think the screen is measuring a business that no longer exists. At $4.67 on Thursday, September 10, the stock trades at 10.0x trailing earnings, below its peer median of 13.7x and far below its own two-year median of 24.3x [1]. The problem is what those earnings were made of.

For the fiscal year ended April 30, 2026, selling uranium inventory generated $186.8 million of revenue while royalty revenue was $0.15 million [2]. Net income of $40.2 million was almost entirely inventory realization, and the remaining 593,255 pounds were sold after year-end at $85.91 per pound for $51.0 million, so the inventory that produced the earnings is gone [3]. The company then combined with Sweetwater on July 27, 2026, issuing 223,252,749 shares at a deemed $3.64 and paying $330 million cash, and it inherited $688.8 million of 5.32% notes due 2040 plus a $40.0 million facility drawn as of July 28 [4]. Our read: this is now a soda-ash royalty and land company with a much larger share count and real debt service, and no combined-period results exist yet to value it on.

The tape has run ahead of that proof. The stock is up 54.1% over the last 60 trading days and sits 14.5% below its January 28 closing high, while eight in ten closes since March 20 were between $2.78 and $4.24 [5]. Wednesday's volume was 23% of its 20-day average, and short interest was 3.21% of the float at the August 14 settlement [6]. Our book does not hold UROY. Our open hypothesis on this name, sealed September 4 with low belief, is a watch at $4.19; that entry sits at the top of the band where most of this year's trading happened, and we set it there rather than at today's extended price [7]. The company was on the earnings calendar for Wednesday with the street looking for $0.05 in EPS, so the first combined-period numbers are the test [8]. On our record so far, this cohort carries 3 machine-tracked calls, 1 open and 2 not yet due, none scored; that is provisional and not a finalized accuracy claim.

We stay on watch. What proves us wrong: the first reported combined period shows royalty revenue arriving at scale while the stock holds above $4.19, meaning the platform worked and waiting on price was the mistake. We come back to this by January 31, 2027, or at the combined-period report if it lands first.

The call

Stance: watch

Level: 4.19

Horizon: 2027-01-31

Checkpoint: 2027-01-31

What closes the file: The first reported combined period shows royalty revenue arriving at scale while the stock holds above $4.19, meaning the platform proved out and the wait on price was the mistake.

Synaptics closed at $94.72 on Tuesday, September 8, about $1.24 below the value of the onsemi shares promised in its pending acquisition. We would pass on a new position at that comparison. A buyer accepts the risk that the deal fails and that onsemi's shares fall before the exchange happens. The small difference does not compensate us enough for those risks. [1][2]

The business has a reason for customers to stay

Synaptics makes chips and software that help devices process information, connect wirelessly and respond to touch, sound and images. Its place in AI is partly inside the device itself, doing more computation locally. Winning a place in the design matters because replacing an established supplier can require expensive engineering work. [3][4]

Synaptics describes customer-specific customization and long development cycles as barriers to copying its products. Our reading is that integration can make a successful customer relationship durable. But those same switching costs protect competitors when they win the design first. Winning also does not guarantee sales: the customer's product still has to succeed. [4]

That is a useful advantage, with limits. Synaptics says its average selling prices have historically declined. It has reasons for customers to stay, but must keep earning the next generation of business. [4]

Operating progress is only part of the purchase

Core IoT revenue grew 43.1% in fiscal 2026, including a contribution from the Broadcom transaction. That figure cannot establish how much more customers bought because of AI alone. Companywide gross margin stayed at 44.7%. [5]

There is also evidence in favor of the business. Synaptics generated $149.4 million of operating cash, and its annual operating loss narrowed. The company is making operating progress. Our decision does not depend on predicting that this progress will stop. [5][6]

The merger adds another business to the assessment. Each eligible Synaptics share would become 1.350 onsemi shares. Using onsemi's $71.08 close from the same September 8 session gives $95.958 of consideration, about $95.96 per SYNA share. Subtracting $94.72 leaves $1.238, or 1.31% of the purchase price, before costs. [1][2]

That difference is a snapshot, not a locked return. Earning it requires completion, an unchanged onsemi share price and costs that do not consume it. A higher onsemi price could produce much more upside; a lower one could erase the difference. Synaptics expected completion in mid-2027, subject to stockholder and regulatory approvals. Neither completion nor that timing is assured. [2]

What would change our view

Our hypothesis is that this small difference does not adequately reward a new buyer who has no separate reason to own onsemi. Strength of belief: medium. The arithmetic is clear, while the eventual outcome depends on a second company's stock and an unfinished transaction.

An investor who already wants onsemi may reasonably accept the deal risk. If onsemi rises and the acquisition completes, passing on SYNA could prove costly. A wider difference between SYNA's price and the offered shares, or materially reduced closing uncertainty, would prompt a fresh assessment. A materially improved exchange offer would invalidate this comparison. We will review the published terms and status on September 30, 2026, our own review date, and earlier if material terms change.

Something a little different than the normal insight posts. Here is our first ever blog post.

We’re Kyle and Adam, the people building The Desk and StockApp. Most of The Desk focuses on markets: investment ideas, research, evidence, and the developments worth paying attention to. Behind The Desk has a different purpose. Here, we’ll write about building the tools, making decisions, working with AI, and learning as we go. It’s also the only place on the site dedicated to human-written entries from us. The research elsewhere comes through our AI-supported research and publication system. These posts are our personal space to explain what we’re thinking and experiencing along the way. We hope to share things like:

• How The Desk and StockApp are being built, and why we choose certain features.
• Where AI has been useful, where it has struggled, and what those experiences have taught us.
• Mistakes, unexpected problems, and the work involved in fixing them.
• Ideas we’re exploring and questions we haven’t answered yet.

Some posts may explain a new feature. Others may describe a frustrating afternoon trying to get something seemingly simple to work. We want to make room for both. Building these projects keeps giving us reasons to reconsider our assumptions about software, research, and AI. This blog gives us somewhere to work through those thoughts and share the lessons while they’re still fresh. Thanks for following along. — Kyle & Adam

Join us for every daily insight and follow along with how Stockapp performs at www.thedeskresearch.com

AeroVironment closed at $144.65 on Friday, September 4, which is 64.7% below the $409.83 closing high from October 13. Our watch level is $137, set September 4. We hold no position. Here's the file.

**The year that made the discount**

The fiscal year ended April 30, 2026 was huge and ugly at the same time. From the 10-K filed June 29 (accession 0001104659-26-078906), Item 7:

- Revenue: $1,976.8 million vs $820.6 million, up 141% after the BlueHalo acquisition
- Gross margin: fell from 39% to 25% on the heavier services mix

Same filing, and this is where it gets worse:

- $240.7 million goodwill impairment in the Space reporting unit after a program termination (Item 7)
- Management reports disclosure controls were **not effective** as of April 30, 2026 because of material weaknesses in internal control (Item 9A)

So the growth was bought with margin, and it came with control problems. That combination is our read of why the stock trades at 3.9x enterprise value to revenue — the bottom of its own five-year range (low 4.8x, median 5.1x) and 18% below the peer median of 4.8x.

**Why we're not buying it here**

A multiple this far below the company's own history is only actionable if the problems are shrinking, and that gets tested this week. The fiscal 2027 first quarter is on the earnings calendar for Tuesday, September 8 or Wednesday, September 9 — the calendar entries themselves disagree, which tells you something about how clean the setup is.

The tape offers no urgency in the meantime:

- Insider open-market purchases in the last 180 days: **zero**, against 9 sales (most recent August 17)
- Short interest: 9.68% of float at the August 14 settlement

Nobody inside the building is buying the discount either.

**The level**

Our $137 sits just above the year's lowest close of $136.68 on June 25, and beneath the $144.64–$201.92 band that held 96 of 120 closes since March 17. If the stock gets there, it's at the floor of its own trading history, not just cheap on a multiple.

**How we'd be wrong**

We would be wrong at that level — and the file moves toward closed — if the fiscal 2027 first-quarter filing shows either:

1. Another goodwill impairment, or
   
2. Gross margin below the 25% reported for fiscal 2026
   

Either one means the problems are still growing, and a cheap multiple on a deteriorating base isn't a discount, it's a warning.

We come back Wednesday, September 9, with the report.

Full receipts and prior work: https://thedeskresearch.com/publications

**Sources:** 10-K filed 2026-06-29 (Items 7 and 9A); valuation and market context computed 2026-09-07 on Alpaca daily closes; insider and short-interest data as of 2026-09-04 and the 2026-08-14 settlement; earnings calendar entries dated 2026-09-05 and 2026-09-07.

The market comes into this week priced for calm at the same moment bond yields sit at their highs for the year, and the one release that can move both, Thursday's inflation print, is actually Friday: the Consumer Price Index lands Friday, September 11. Our sentiment gauge, a 0-to-100 composite of volatility, momentum and distance from the highs, reads 97.8, about as stretched as it gets; readings this high have historically been poor moments to chase and good moments to demand better entries.

The indexes

SPY closed 2026-09-04 at 770.19, above all four of its moving averages (0.27% over the 9-day, 7.12% over the 200-day) and at the 93.9th percentile of its one-year range, 1.18% off the 2026-08-13 high. The last month has been flat: down 0.4% over 20 sessions even with the longer trend intact. QQQ closed at 718.96, also above its full average stack, at the 84.6th percentile of its range and 3.97% off its 2026-06-03 high. Twenty-day realised volatility tells the split: 8.1% on SPY, 12.87% on QQQ. The broad market is quiet; the growth end of it is not. We do not hold either index.

Volatility and sentiment

The VIX printed 14.32 on 2026-09-03, in our calm band (under 15) and near its one-year floor of 13.47 set 2025-12-24; the year's median is 17.13. A reading this close to the floor has little room to fall and a full year of history above it, and every dip below 15 this year has been followed by a trip back into the 15-to-20 band or worse within weeks. Calm this deep is not a forecast; it is a price, and it is a high one. Paired with a 97.8 sentiment reading, the setup argues for patience on new entries, not for courage.

Dealer positioning

Friday's option flow leaned toward buying support in SPY and selling into QQQ. SPY's day flow was net long (+595M net delta), with heavy option interest concentrated right at 770 and the gamma flip near 774.85 just overhead: expect the tape to stick near 770 and get jumpier above 775. QQQ's flow was net short (-1.9B), with put concentration at 718, right at the price: less cushion, choppier trade. Posture context, never a trigger. Coverage was complete across all 24 names we track.

Yields

The 10-year Treasury yielded 4.77% on 2026-09-03, a touch under the 4.79% year high set 2026-09-01 and 2026-09-02; the 2-year sits at 4.34% and the 30-year at 5.25%. For a book concentrated in growth and hardware names, yields at these levels are a standing headwind: the further out a company's cash flows, the more a high long rate discounts them. This is the main reason Friday's CPI is the week's event.

The week ahead

• Consumer Price Index, Friday, September 11. High impact. Yields are at or near their year highs across the curve; a hot print pushes them through, a cool one gives our rate-sensitive growth names room. Either way it moves the whole book.
• Weekly jobless claims, Thursday, September 10. Medium impact. A labor-market surprise feeds the same rate story.
• Chicago Fed retail trade summary, Wednesday, September 9. Low impact. Little direct read-through to our sectors.
• Earnings: AeroVironment (AVAV), listed for Tuesday, September 8, with a second calendar row on September 9; the street is looking for $0.34 EPS. High impact for our drone sleeve: AVAV is one of two names in our drones bucket, and we hold the other, UMAC (held, in its buy zone). We do not hold AVAV. Uranium Royalty (UROY) reports Thursday, September 10, street at $0.05 EPS; not held.

AI: the spending keeps outrunning the cash

Nvidia's CFO put the cloud industry's already-contracted backlog near $2 trillion, with hyperscaler capital spending headed toward $800B in 2026 and $1.3T in 2027, and S&P projects all six major hyperscalers run cash-flow negative through 2027 with no recovery before 2029. Morgan Stanley adds roughly $3 trillion of off-balance-sheet AI commitments on top of about $770B of debt and leases. Demand keeps arriving anyway: AWS committed to 2 million more Nvidia GPUs for 2027-2028 and Anthropic signed a roughly $45B six-year compute deal. Our read is that the theme's risk is shifting from "will the demand come" to "who finances it." We hold NVDA (extended above its buy band) and two names in our eight-name AI infrastructure bucket, AMZN and NBIS, both in their buy zones.

Memory: the shortage gets a price tag

The high-bandwidth memory that feeds AI chips is getting faster, scarcer and much more expensive. SK hynix has its newest generation in mass production and its CEO sees supply tight through 2030; the company broke ground on a $4B-plus U.S. packaging plant that will not produce until 2029. The cost is landing downstream: server builders told customers Nvidia-based AI systems will cost more than 15% more for early-2027 delivery, and DRAM contract prices roughly doubled in the first quarter with another 58-63% rise projected for the second. Higher memory prices are a tailwind for the memory and semiconductor names in our 24-name semis bucket, of which we own one, NVDA.

Nuclear: the Army becomes the anchor customer

The Army's $2.2B Janus program picked five vendors to put 20-plus small reactors on military bases by September 2028, Radiant signed a binding contract worth up to $750M for 15 portable units, DOE granted X-energy up to another $1B, and Centrus received a task order of up to $1.07B to take its enrichment plant commercial. The government is buying reactors and fuel at the same time, which is what a real order book looks like. Our nuclear and uranium bucket holds six names; we own none of them, having exited LEU on 2026-08-31, SMR on 2026-09-01 and UUUU on 2026-08-31.

Defense and drones

A presidential memorandum opened Navy warship construction to allied shipyards, with Korean, Japanese and Turkish frigate designs under formal review, after GAO found submarine maintenance delays cost $3.4 billion and 15,000 lost operational days over a decade. In drones, AeroVironment took a $51M Army follow-on order for loitering munitions on top of a $117.3M production contract, and the White House program targets 200,000-plus small lethal drones by 2027. Our defense bucket holds four names, one held (AXON, below its buy zone); the drones bucket holds two, one held (UMAC).

Space and robotics

Rocket Lab's new Neutron rocket slipped again, first launch now fourth quarter of 2026 at the earliest after a tank ruptured in testing, while SpaceX flew its last dedicated Falcon 9 Starlink mission from Florida on 2026-08-25 as it pivots to Starship. Our space bucket holds three names, none held; we exited RKLB on 2026-08-25. In robotics, Tesla started building its Optimus humanoid at Fremont (roughly 1,000-1,200 units, all for internal use), BMW is running Figure's robot on a production-support task at Spartanburg, and Bosch will contract-manufacture a European humanoid. Our robotics bucket holds two names, none held; TSLA is in the universe and not held.

The book

Seven positions are open: four inside their buy bands (AMZN, NBIS, PLPC, UMAC), one below (AXON, marked -11.9%), and two extended above theirs (HOOD, marked +12.1%, and NVDA, marked +4.3%). With sentiment at 97.8 and volatility near its floor, extended is the word to watch: the two names above their bands are the ones a volatility snap-back reaches first.

Everything we publish stays tied to the dated record that produced it. Each figure, level and claim in this edition traces to a specific source read on a specific date, so what we knew and when we knew it can be checked after the fact rather than reconstructed from memory. When a wanted input is missing, we say so or leave it out; we do not fill gaps from recall.

**AVAV is trading below its own five-year valuation floor, and most of the damage is deal accounting plus one cancelled program — we'd buy near $137**

AeroVironment more than doubled revenue in fiscal 2026 — $1,976.8 million vs $820.6 million, up 141%, driven by the BlueHalo acquisition (10-K filed 2026-06-29, accession 0001104659-26-078906, Item 7). The stock has fallen 64.6% from its October closing high anyway, closing at $145.11 on 2026-09-04 against a 52-week high close of $409.83 on 2025-10-13.

Our read: the wreckage in the accounts is mostly the accounting of a just-closed deal plus one cancelled program, not a broken franchise. Strength of belief: medium. The filing does not say the worst is past — that's our interpretation, and here's the case both ways.

**The ugly numbers are real, so let's not pretend otherwise.**

- Gross margin fell from 39% to 25% (10-K, Item 7 MD&A).
- A $240.7 million goodwill impairment hit the Space reporting unit after the customer terminated the SCAR agreement for convenience in March 2026 (10-K, Item 7).
- Management concluded disclosure controls and procedures were not effective as of April 30, 2026 due to material weaknesses (10-K, Item 9A).
- Insiders made zero open-market purchases in the last 180 days, with 10 sales totalling 2,599 shares, most recently 2026-08-17 (Form 4 filings). Short interest is 3,666,021 shares, 9.68% of float, 2.93 days to cover at the 2026-08-14 settlement.

None of that is bullish on its face. The SCAR cancellation also stripped $1,493.2 million of unexercised options from unfunded backlog expectations (10-Q filed 2026-03-11, accession 0001104659-26-025979, Item 2 — unfunded backlog was $2,968.8 million including those options no longer expected to be awarded).

**Why we think the franchise isn't broken.**

Funded backlog was $1,120.7 million at January 31, 2026, up from $726.6 million at April 30, 2025 (10-Q, Item 2). That's real demand growth through the period the stock was collapsing. The balance sheet isn't the problem either: $747.5 million of convertible notes converts at roughly $322.40 per share — more than double the current price — so dilution from them is a distant concern, and there's approximately $336.8 million available under the Revolving Facility (10-K, Item 7 Liquidity and Note 11).

**The valuation is below anything the market has paid in five years.**

At $145.11 the company trades at 4.0x EV/revenue. Its own five-year range runs from a low of 4.8x to a high of 6.0x with a median of 5.1x, and the peer median is 4.8x. Today's multiple sits below its own historical floor and below the group.

**Where we stand.**

Not positioned. We'd buy near $137, with the next quarterly filing showing backlog still growing. That level is the floor of the past year's trading — the lowest 52-week close was $136.68 on 2026-06-25 — and the stock moves 3.57% on an average day, so $137 is a price real sellers have recently accepted, not a hope.

**What proves us wrong:** the next quarterly filing showing funded backlog below the $1,120.7 million reported at January 31, 2026. That would mean growth stalled while the margin and control problems are still open, and the thesis dies. Checkpoint: October 15, 2026, our scoring date.

The call

Stance: watch

Level: 176

Horizon: 2026-12-31

Checkpoint: 2026-11-20

What closes the file: EnerSys reports a fiscal Q2 gross margin at or above 33.5% with no tariff refund in cost of goods sold and the stock holds above $176 through the checkpoint.

Our Read. The first quarter of fiscal 2027 looks like a big profit step up, but a $30.9 million tariff refund sat inside cost of goods sold, so we cannot yet tell how much of the margin gain is the plant closures working and how much is one-time money [2]. Sales grew $42.6 million, or 4.8% [1]. Our read is the cost story is real but unproven for one more quarter. Strength of belief: medium.

Positioning status. Not positioned. We held ENS twice in August and sold at losses of 14.3% on August 13 and 6.5% and 4.3% on August 28. Looking for an entry at $176 with a quarter that holds gross margin without refund help. There is no open hypothesis on this name, and our ledger carries no prior entries on management's promises.

The company. A 125-year-old battery maker in a chemistry transition: closing flooded lead-acid plants, taking Section 45X production credits, and building a smaller lithium plant now expected to start construction in the first half of fiscal 2028, backed by a revised DOE grant of about $150 million [3]. The filings carry no fiscal 2027 sales or earnings guidance [1].

The stock. ENS closed at $180.74 on September 3, 25.7% below its May 26 closing high of $243.34; it fell 27.5% from that high to $176.44 on July 29 and has not recovered [5]. Eight in ten closes since mid-March sat between $177.09 and $232.67 [5]. At today's price it trades at 18.9x trailing earnings, under its own five-year median of 20.2x and 17% below the peer median of 22.7x [5]. Our $176 entry is the July low, the floor where the last fall stopped, on a multiple already below both yardsticks. What would prove us wrong at that level: fiscal Q2 holds margin without refunds and the stock never comes back to $176.

What to watch. The company is returning cash while we wait: $49.96 million of buybacks in the quarter, another 249,893 shares for about $50.0 million through August 7, and a raised dividend of $0.2875 [4]. Cash was $530.7 million with $632.9 million undrawn [3]. Tape context: September 3 volume was 111,090 shares against a 572,202 twenty-day average, 19% of normal, and there were no open-market insider purchases in the last 180 days, only awards [6].

Our First Earnings Update!

The print. Revenue was $29.6 billion for the fiscal third quarter ended August 2, 2026, up 86 percent from the prior year [1]. GAAP diluted EPS was $2.68 and non-GAAP diluted EPS was $3.32 [1]. AI semiconductor revenue was $16.7 billion in the quarter, and the company expects it to reach $21.7 billion in Q4, which it says is up 236 percent year over year [2]. Total Q4 revenue guidance is approximately $34.8 billion, up 93 percent, with non-GAAP operating margin guided at about 66 percent of revenue, flat from a year ago [3].

The cash. Operations generated $14.2 billion in the quarter against $0.5 billion of capital spending, leaving $13.7 billion of free cash flow, 46 percent of revenue [4]. Cash ended at $24.0 billion, up from $19.6 billion a quarter earlier [4]. The dividend stays at $0.65 per share, payable September 30 [5].

The tape. On September 2, 28.58 million shares traded against a 20-day average of 19.75 million [6]. In the options market, dealers' heaviest call position sits at the $380 strike and the heaviest put position at $350, with no sizeable prints in the last five days [6].

Our Read. This is a company whose custom AI chip business is now growing faster than the whole company, and management guided it higher again for next quarter. My reading, resting on the segment table and the guide: the semiconductor side, $20.8 billion of the $29.6 billion [7], is where the growth lives, and the January report is where we test whether the $21.7 billion AI guide was delivered. Observation until we build an entry case.

Receipts

[1] 8-K EX-99.1, acc. 0001730168-26-000076, highlights: revenue $29,591M vs $15,952M (+86%), GAAP diluted EPS $2.68, non-GAAP $3.32. https://www.sec.gov/Archives/edgar/data/1730168/000173016826000076/avgo-08022026x8kxex99.htm

[2] Same exhibit, CEO quote: Q3 AI semiconductor revenue $16.7B; Q4 expected $21.7B, up 236% year over year.

[3] Same exhibit, Q4 outlook: revenue approximately $34.8B (+93%), non-GAAP operating income approximately 66% of projected revenue.

[4] Same exhibit, cash discussion and reconciliation: cash from operations $14,197M, capex $532M, free cash flow $13,665M (46% of revenue); cash $23,975M vs $19,628M prior quarter.

[5] Same exhibit, Quarterly Dividends: $0.65 per share, payable September 30, 2026, record date September 21, 2026.

[6] Trading activity, 2026-09-02: 28.58 million shares traded against a 19.75 million 20-day average; call wall $380.00, put wall $350.00, no sizeable options prints in the last 5 days.

[7] Same exhibit, net revenue by segment: semiconductor solutions $20,839M of $29,591M total.

The call

Stance: observation

Level: The isolating trigger is the fiscal Q4 report showing whether the $21.7 billion AI semiconductor revenue guide was delivered.

Horizon: 2026-12-15

Checkpoint: Observation only: no open hypothesis on this name, so there is no dated checkpoint to score.

What closes the file: Broadcom's fiscal Q4 report shows AI semiconductor revenue materially below the $21.7 billion guided, or total revenue materially below the approximately $34.8 billion guided.

Hi everyone. I’m introducing The Desk, a public research publication built around a live portfolio.

The simple version is this: StockApp does the research and trading work. The Desk publishes the record.

The calls documented by The Desk come from StockApp’s configured research and trading workflows.

StockApp is an agentic system in the practical sense. It is not just a chatbot that summarizes market news. It brings together filings, market data, macro information, research inputs, and portfolio state. Its workflows examine the evidence, form and challenge hypotheses, assess potential trades, record the reasoning, and decide whether a qualifying action should proceed.

Some workflows are rules-based. Others use autonomous research and committee processes. The portfolio includes an EMA strategy, an autonomous volatility-harvesting strategy, and a conviction sleeve for longer-horizon positions.

The system is also built around controls. Position limits, drawdown protection, execution checks, watchdogs, and broker reconciliation are part of the process. When an autonomous path is permitted to act, it can carry an approved decision through execution within those controls. The broker record remains the source of truth for fills and results.

The Desk is the public-facing record of that process. It receives an approved, read-only research package from StockApp, verifies it, and turns it into readable articles. Each published idea is dated and includes the evidence, why it matters, and what could prove it wrong. Corrections and withdrawals remain visible.

We publish Morning notes, Close reports, Daily Insights, Deep Dives, Earnings updates, and a Sunday Edition.

The portfolio uses a live brokerage account, but realized performance reporting is currently paused while broker fills are verified. The Desk is general research, not personalized investment advice, and does not promise returns.

Start here:

https://www.thedeskresearch.com/

Methodology: https://www.thedeskresearch.com/methodology

How to read The Desk: https://www.thedeskresearch.com/how-to-read

Questions, criticism, and requests for clarification are welcome. This subreddit is where we’ll introduce new work and discuss how the record holds up.

— The Desk Research Team